911426-64-7

Basic information

• Product Name: tert-butyl 4-[2-({[1-(3,5-dimethylphenyl)vinyl]oxy}methyl)indan-2-yl]-1-piperazinecarboxylate
• Synonyms: tert-butyl 4-[2-({[1-(3,5-dimethylphenyl)vinyl]oxy}methyl)indan-2-yl]-1-piperazinecarboxylate
• CAS NO: 911426-64-7
• Molecular Weight: 462.632
• Mol File: 911426-64-7.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: tert-butyl 4-[2-({[1-(3,5-dimethylphenyl)vinyl]oxy}methyl)indan-2-yl]-1-piperazinecarboxylate(CAS DataBase Reference)
• NIST Chemistry Reference: tert-butyl 4-[2-({[1-(3,5-dimethylphenyl)vinyl]oxy}methyl)indan-2-yl]-1-piperazinecarboxylate(911426-64-7)
• EPA Substance Registry System: tert-butyl 4-[2-({[1-(3,5-dimethylphenyl)vinyl]oxy}methyl)indan-2-yl]-1-piperazinecarboxylate(911426-64-7)

Safety Data

• Hazardous Substances Data: 911426-64-7(Hazardous Substances Data)

Upstream product

• 1271-66-5 dimethyltitanocene 
• 911426-63-6 tert-butyl (RS)-4-(2-{[(3,5-dimethylbenzoyl)oxy]methyl}indan-2-yl)-1-piperazinecarboxylate 

Downstream Products

• 911426-65-8 tert-butyl (RS)-4-(2-{[1-(3,5-dimethylphenyl)ethoxy]methyl}indan-2-yl)-1-piperazinecarboxylate 

Relevant articles and documents

Indanyl-piperazine compounds

A compound selected from those of formula (I): wherein: R3 represents a hydrogen atom, and R1 and R2 together with the carbon atoms carrying them form a benzene, naphthalene or quinoline ring structure, each of the ring structures being optionally substituted, ?or R1 represents a hydrogen atom, and R2 and R3 together with the carbon atoms carrying them form a benzene, naphthalene or quinoline ring structure, each of the ring structures being optionally substituted, n represents 1 or 2, —X— represents a group selected from —(CH2)m—O-Ak-, —(CH2)m—NR4-Ak-, —(CO)—NR4-Ak- and —(CH2)m—NR4-(CO)—, ?m represents an integer between 1 and 6 inclusive, Ak represents an optionally substituted alkylene chain, and R4 represents a hydrogen atom or an alkyl group, Ar represents an aryl or heteroaryl group, its enantiomers, diasteroisomers, and addition salts thereof with a pharmaceutically acceptable acid. Medical products containing the same which are useful in the treatment of conditions requiring a serotonin reuptake inhibitor and/or NK1 antagonist.